Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lilly Teams Up With Boehringer Ingelheim To Boost Abemaciclib

Executive Summary

The two big pharmas are working together in oncology in an effort to advance combination therapies in both their growing, but young oncology pipelines.


Related Content

Boehringer Increasingly Looking Outside For Oncology Growth
Lilly's Abemaciclib Hit Leaves It Down But Not Out
Lilly Awaits New Rewards For SGLT-2 Diabetes Drug Jardiance
2Q Pharma Results Preview: What Lies Ahead
Deal Watch: Flagship Ventures Doubles Down On Microbiome
Lilly Playing Catch Up In Oncology
ASCO Puts A Spotlight On CDK4/6 Category Ahead Of New Competition


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts